Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 113265
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.113265
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.113265
Table 4 GRADE evidence assessment1
| Comparison | Outcome | Studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Certainty |
| Any anticoagulant vs control | Thrombotic events | 1 RCT, 8 Obs | Mixed | Serious | Not serious | Not serious | Serious | Low |
| Fondaparinux vs others | Thrombotic events | 5 Obs | Observational | Serious | Serious | Not serious | Serious | Very low |
| Argatroban vs bivalirudin | Thrombotic events | 3 Obs | Observational | Serious | Not serious | Not serious | Serious | Low |
| Any anticoagulant vs control | Major bleeding | 1 RCT, 10 Obs | Mixed | Serious | Serious | Not serious | Serious | Very low |
| Any anticoagulant vs control | Mortality | 1 RCT, 8 Obs | Mixed | Serious | Serious | Not serious | Serious | Very low |
- Citation: Rehman A, Abid M, Jamil H, Siddique S, Parkash S, Nasrullah F, Sapna F, Lohana B, Lohana K, Jawed I, Tufail M, Sharaf MS. Comparative effectiveness of parenteral anticoagulants (fondaparinux, argatroban, bivalirudin) in heparin-induced thrombocytopenia: A systematic review. World J Methodol 2026; 16(2): 113265
- URL: https://www.wjgnet.com/2222-0682/full/v16/i2/113265.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i2.113265